Jazz Pharma Announces Offering Of $500 Million Of 1.50% Exchangeable Senior Notes Due 2024 - BioLegacy Research

Jazz Pharma Announces Offering Of $500 Million Of 1.50% Exchangeable Senior Notes Due 2024

Post author:Sam
Post published:August 17, 2017
Post category:BioPharma

Life Sciences Jobs …
Source: BioSpace